TOMSK, Feb 19 – RIA Tomsk. The laboratory of new dosage forms will appear in Tomsk Polytechnic University (TPU); here scientists will develop technologies, which will allow to control the movement of drugs in the body to precisely influence, for example, on area of heart attack or on a cancer, the press-service of the university informed on Friday.
According to the university, the laboratory organisation began in January of this year within the frameworks of at TPU organized centre of Russian-speaking Academic Science Association (RASA). The laboratory was headed by professors Gleb Sukhorukov (Queen Mary University of London) and Dmitry Gorin (Saratov State University).
"Polytechnics in cooperation with Tomsk and foreign medical scientists will develop technologies of operated medical products' delivery in the patient's organism. This is about microscopic spherical nanocapsules. Their sizes are comparable with erythrocytes – red blood cells", – is told in the message.
According to the press-service, scientists from other centres RASA have already developed methods of nanocapsules creation and ways of their introduction into the organism – doctors take the patient's blood, add nanocapsules in it and return blood to the organism. As the body does not perceive blood as something alien, the medicine is not rejected."We will concentrate on physical methods of nanocapsules delivery. One of our tasks will be developing of remotely controlled systems, by means of which doctor can direct the drug to specific point of the patient's organism", - words of Sukhorukov are given in the message.
Scientists plan to use ultrasound, light and a variable magnetic field to control capsules. It will allow to raise to a new level the treatment of diseases at which the impact point is necessary - to destroy the cancer tumour, to localise the infarction area, to eliminate a blood clot in vessel (can lead to stroke) or to direct insulin to the place of the greatest congestion of sugar in the organism of the diabetic.